-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $134

Benzinga·11/03/2026 13:28:26
语音播报
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $105 to $134.